219 related articles for article (PubMed ID: 17574487)
1. On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Kim Y; Tomé WA
Med Biol Eng Comput; 2007 Nov; 45(11):1045-51. PubMed ID: 17574487
[TBL] [Abstract][Full Text] [Related]
2. The impact of dental metal artifacts on head and neck IMRT dose distributions.
Kim Y; Tomé WA; Bal M; McNutt TR; Spies L
Radiother Oncol; 2006 May; 79(2):198-202. PubMed ID: 16677729
[TBL] [Abstract][Full Text] [Related]
3. The dosimetric and radiobiological impact of calculation grid size on head and neck IMRT.
Srivastava SP; Cheng CW; Das IJ
Pract Radiat Oncol; 2017; 7(3):209-217. PubMed ID: 27847266
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of two commercial CT metal artifact reduction algorithms for use in proton radiotherapy treatment planning in the head and neck area.
Andersson KM; Dahlgren CV; Reizenstein J; Cao Y; Ahnesjö A; Thunberg P
Med Phys; 2018 Oct; 45(10):4329-4344. PubMed ID: 30076784
[TBL] [Abstract][Full Text] [Related]
5. Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images.
Hansen CR; Christiansen RL; Lorenzen EL; Bertelsen AS; Asmussen JT; Gyldenkerne N; Eriksen JG; Johansen J; Brink C
Acta Oncol; 2017 Jun; 56(6):874-878. PubMed ID: 28464749
[TBL] [Abstract][Full Text] [Related]
6. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
8. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
10. Myths, facts and scope of spinal cord tolerance dose revision in Intensity modulated SIB treatment of locally advanced head and neck cancer: A dosimetrical and radiobiological demonstration.
Patel G; Mandal A; Choudhary S; Mishra R; Shahi U; Mishra H
Cancer Radiother; 2021 Feb; 25(1):8-12. PubMed ID: 33293203
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
12. Geometric and dosimetric impact of 3D generative adversarial network-based metal artifact reduction algorithm on VMAT and IMPT for the head and neck region.
Nakamura M; Nakao M; Imanishi K; Hirashima H; Tsuruta Y
Radiat Oncol; 2021 Jun; 16(1):96. PubMed ID: 34092240
[TBL] [Abstract][Full Text] [Related]
13. Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution.
Sumida I; Yamaguchi H; Kizaki H; Aboshi K; Tsujii M; Yoshikawa N; Yamada Y; Suzuki O; Seo Y; Isohashi F; Yoshioka Y; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):779-86. PubMed ID: 25936816
[TBL] [Abstract][Full Text] [Related]
14. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
15. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.
Johansson J; Blomquist E; Montelius A; Isacsson U; Glimelius B
Radiother Oncol; 2004 Aug; 72(2):129-38. PubMed ID: 15297132
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional dose prediction and validation with the radiobiological gamma index based on a relative seriality model for head-and-neck IMRT.
Hamatani N; Sumida I; Takahashi Y; Oda M; Seo Y; Isohashi F; Tamari K; Ogawa K
J Radiat Res; 2017 Sep; 58(5):701-709. PubMed ID: 28430990
[TBL] [Abstract][Full Text] [Related]
17. The effects of the orthopedic metal artifact reduction (O-MAR) algorithm on contouring and dosimetry of head and neck radiotherapy patients.
Sillanpaa J; Lovelock M; Mueller B
Med Dosim; 2020 Spring; 45(1):92-96. PubMed ID: 31375297
[TBL] [Abstract][Full Text] [Related]
18. Risk adaptive planning with biology-based constraints may lead to higher tumor control probability in tumors of the canine brain: A planning study.
Radonic S; Schneider U; Besserer J; Meier VS; Rohrer Bley C
Phys Med; 2024 Mar; 119():103317. PubMed ID: 38430675
[TBL] [Abstract][Full Text] [Related]
19. Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.
Kierkels RG; Korevaar EW; Steenbakkers RJ; Janssen T; van't Veld AA; Langendijk JA; Schilstra C; van der Schaaf A
Radiother Oncol; 2014 Sep; 112(3):430-6. PubMed ID: 25220369
[TBL] [Abstract][Full Text] [Related]
20. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
